Advanced search
Add to list

Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice

(2017) JOURNAL OF CROHNS & COLITIS. 11(suppl. 1). p.S478-S478
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Van den Bossche, Lien et al. “Ursodeoxycholic Acid and Its Taurine/glycine Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.” Journal of Crohns & Colitis. Vol. 11. 2017. S478–S478. Print.
APA
Van den Bossche, L., Hindryckx, P., Devisscher, L., Devriese, S., Van Welden, S., Holvoet, T., Vilchez Vargas, R., et al. (2017). Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice. JOURNAL OF CROHNS & COLITIS (Vol. 11, pp. S478–S478). Presented at the 12th Congress of ECCO.
Chicago author-date
Van den Bossche, Lien, Pieter Hindryckx, Lindsey Devisscher, Sarah Devriese, Sophie Van Welden, Tom Holvoet, Ramiro Vilchez Vargas, et al. 2017. “Ursodeoxycholic Acid and Its Taurine/glycine Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.” In Journal of Crohns & Colitis, 11:S478–S478.
Chicago author-date (all authors)
Van den Bossche, Lien, Pieter Hindryckx, Lindsey Devisscher, Sarah Devriese, Sophie Van Welden, Tom Holvoet, Ramiro Vilchez Vargas, Marius Vital, Dietmar H Pieper, Julie Vandenbussche, Lynn Vanhaecke, Tom Van de Wiele, Martine De Vos, and Debby Laukens. 2017. “Ursodeoxycholic Acid and Its Taurine/glycine Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.” In Journal of Crohns & Colitis, 11:S478–S478.
Vancouver
1.
Van den Bossche L, Hindryckx P, Devisscher L, Devriese S, Van Welden S, Holvoet T, et al. Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice. JOURNAL OF CROHNS & COLITIS. 2017. p. S478–S478.
IEEE
[1]
L. Van den Bossche et al., “Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice,” in JOURNAL OF CROHNS & COLITIS, Barcelona, Spain, 2017, vol. 11, no. suppl. 1, pp. S478–S478.
@inproceedings{8521084,
  author       = {Van den Bossche, Lien and Hindryckx, Pieter and Devisscher, Lindsey and Devriese, Sarah and Van Welden, Sophie and Holvoet, Tom and Vilchez Vargas, Ramiro and Vital, Marius and Pieper, Dietmar H and Vandenbussche, Julie and Vanhaecke, Lynn and Van de Wiele, Tom and De Vos, Martine and Laukens, Debby},
  booktitle    = {JOURNAL OF CROHNS & COLITIS},
  issn         = {1873-9946},
  language     = {eng},
  location     = {Barcelona, Spain},
  number       = {suppl. 1},
  pages        = {S478--S478},
  title        = {Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice},
  volume       = {11},
  year         = {2017},
}

Web of Science
Times cited: